In vitro insulinotropic actions of various extracts of Moringa oleifera leaves by Ojo, Opeolu
1 
 
In vitro insulinotropic actions of various extracts of Moringa oleifera leaves 
Opeolu O Ojo 
Chevron Biotechnology Centre, Modibbo Adama University of Technology, PMB 2076, Yola, 
Nigeria  and SAAD Centre for Diabetes and Pharmacy, School of Biomedical Sciences, 
University of Ulster, Coleraine, BT52 1SA, UK  
 
Correspondence author: Dr. Opeolu O. Ojo, Chevron Biotechnology Centre, Modibbo Adama 
University of Technology, Yola, Adamawa State, PMB 2076, Nigeria. E-mail: 
o.ojo@mautech.edu.ng, Tel: +442870123206 
 
ABSTRACT 
This study investigated the in vitro insulin-releasing and cytotoxic effects of various extracts 
of Moringa oleifera. Pulverized Moringa oleifera leaves were sequentially extracted with 
four solvents. BRIN-BD11 cells were grown in an atmosphere of 5% CO2 and 95% air in 
RPMI-1640. Insulin and LDH assays were carried out using Krebs Ringers Bicarbonate 
buffer. Insulin concentration was measured by radioimmunoassay and LDH release was 
assessed using a commercially available non-radioactive assay kit (Promega, UK).  Aqueous 
extraction produced the best yield (361 mg/20kg powder). Acute incubation of BRIN-BD11 
cells with different extracts of M. oleifera produced a concentration-dependent stimulation of 
insulin-release at concentrations ≥10 µg/ml. The aqueous extract produced the best 
insulinotropic effect, with a maximum stimulation of 347% (P<0.001) of basal rate at 100 
µg/ml and the lowest stimulating concentration of 0.1 µg/ml. Dichloromethane and acetone 
extracts produced similar stimulatory effects (130% of basal rate, 100 µg/ml, P<0.01). 
Insulin-releasing effects of the four extract were not associated with beta cell cytotoxicity. 
These results showed that extracts of M. oleifera possess insulinotropic effects and encourage 
further studies to uncover the physiological mechanism involved.   
 












Records abound of the folkloric use of various plant-based preparations in the management of 
many diseases worldwide (Newman and Craig, 2007). Advances in science and technology 
exemplified by improved separation and purification techniques have significantly aided 
scientific investigations of the efficacy of many therapeutic natural products (Conlon et al, 
2007). In addition, the development of various cell-lines for in vitro screening of drug 
candidates (McClenaghan et al, 1996) and various animal models of human diseases (King, 
2012) has further encouraged bio-prospecting for novel agents that could cater for unmet 
needs in the management of many human diseases, including diabetes mellitus.  Increasing 
incidence of diabetes (Wild et al, 2004) and several challenges facing its management have 
motivated the search for novel agents with anti-diabetic effects.  
Moringa oleifera is a tropical tree commonly found in Africa, the sub-Himalayan tracts of 
India, Pakistan, Bangladesh and Afghanistan (Fahey, 2005). In addition to its several other 
uses, many recent studies have investigated nutritional and medicinal properties of M. 
oleifera, reporting its antibiotic (Caceres et al, 1991; Dahot, 1998), antitrypanosomal 
(Mekonnen et al, 1999), hypotensive (Faizi et al, 1994), anti-cancer (Costa-Lutofo et al, 
2005), anti-inflammatory (Ezeamuzie et al, 1996), hypocholesterolemic (Mehta et al, 2003) 
and hypoglycemic activities (Kar et al, 2003). Several bioactive compounds, including 
carbamates and thiocarbamates (Francis et al, 2004) (Table 1), isothiocyanates and several 
peptides (Fahey, 2005) have been isolated from the pod, leaves and roots of M. oleifera. This 
study investigated insulin-releasing effects of various extracts of M. oleifera, using clonal 
pancreatic cell-line, BRIN-BD11. We also assessed cytotoxic effects of the extracts, using the 






MATERIALS AND METHODS 
Plant material preparation 
Fresh leaves of M. oleifera were collected in August 2013 around Sangere Village in Girei 
Local Government Area of Adamawa State, Nigeria. After botanical identification, a voucher 
specimen (No: OO2013-04) was deposited in the herbarium of Chevron Biotechnology 
Centre, Modibbo Adama University of Technology, Yola. M. oleifera leaves were dried at 
room temperature and pulverized using a pestle and mortal into fine powder. Ground plant 
material was sequentially extracted with dichloromethane, acetone, ethylacetate and water. 
Briefly, dichloromethane extract was prepared by soaking 20g of the ground powder in 50ml 
of the solvent with intermittent shaking for 3 days. The mixture was first filtered with a 
double-layer of muslin cloth and then Whatman No.1 filter paper. The resultant residue was 
rinsed twice with dichloromethane and all the filtrates were pooled together. The solvent was 
removed from the extract at 40
o
C in an oven. After complete drying, the yield of the extract 
was ascertained as presented in Table 2. The residue was subjected further extraction 
sequentially with ethylacetate, acetone and water following the same extraction procedure 
described for dichloromethane.  
 
 In vitro insulin-releasing studies 
In vitro insulin-releasing actions of the various extracts of M. oleifera were assessed using 
BRIN-BD11 rat clonal β-cells seeded into 24-well plates (10
5
 cells per well). Cells were 
grown at 37
o
C in an atmosphere of 5% CO2 and 95% air in RPMI-1640 supplemented with 
10% (v/v) foetal calf serum, antibiotics (100 U/ml penicillin, 0.1mg/ml streptomycin) and 
11.1mM glucose as previously described (Abdel-Wahab et al, 2008; Mechkarska et al, 2010; 
Ojo et al, 2011). Prior to acute tests, cells were pre-incubated for 40 min at 37
o
C in Krebs 
Ringers Bicarbonate (KRB) buffer (pH 7.4) supplemented with 0.5% (w/v) BSA and 1.1mM 
glucose. Test incubations were performed for 20 min at 37
o
C in the presence of 5.6mM 
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glucose and graded doses of different M. oleifera extracts (0 - 100µg/ml). After incubation, 
aliquots of cell supernatants were removed for insulin measurement by radioimmunoassay. 
 
Measurement of insulin concentration 
Measurement of insulin concentration was carried out as described by Flatt and Bailey (1981) 
using sodium phosphate (40 mM) supplemented with thiomerosal (0.02% w/v) and BSA (1% 
w/v). Insulin standard curve was prepared using crystalline rat insulin over a concentration 
range of 0.039 to 20.0 ng/ml. Insulin antibody (100µl, 1:40,000 dilution) and 
125
I-labelled 
tracer (100µl, 10,000 cpm per tube) were added in triplicate to insulin standard and unknown 
samples and incubated for 48 hours at 4
o
C.  Following the addition of a suspension of 5% 
(v/v) dextran coated charcoal (5% w/v), the mixture was further incubated for 20 min, 
centrifuged (2500 rpm, 4
o
C) and decanted for the measurement of free 
125
I-insulin (now 
bound to charcoal) using a gamma counter. Insulin concentration were interpolated from the 
standard curve plotted using a spline curve-fitting algorithm using known concentrations of 
rats insulin.  
Assessment of cytotoxicity 
To determine cytotoxicity of plant extracts, BRIN-BD11 cells were seeded into 24-multiwell 
plates as previously described (Ojo et al, 2011). Following overnight culture in RPMI 1640, 
cells were pre-incubated in KRB buffer containing 1.1 mM glucose (1.0 ml) for 40 min at 37 
C.  This was followed by a 20-min incubation with KRB buffer containing 5.6mM glucose 
in the presence or absence of the various extracts of M. oleifera or DMSO (40%). 
Concentrations of lactate dehydrogenase (LDH) in the cell assay supernatants were measured 
using a CytoTox96 nonradioactive cytotoxicity assay kit (Promega, Madison, WI, USA) 





Results are expressed as mean ±  S.E.M. and values were compared using two-way ANOVA 
followed by Newman-Keuls post-hoc test. Groups of data were considered to be significantly 




Figure 1 presents yield obtained from the sequential extraction of M. oleifera leaf powder 
with the different solvents. Extraction with ethylacetate produced the lowest yield while the 
highest yield was obtained for aqueous extraction.  
 
Insulin- releasing effects of M. oleifera extracts 
The basal rate of release of insulin from BRIN-BD11 cells in the presence of 5.6 mM glucose 
alone was 0.91 ± 0.04 ng/10
6
 cells/20 min. Addition of alanine (10mM) to the assay buffer 
increased this rate to 3.14 ± 1.14 ng/10
6
 cells/20 min (P < 0.001; n = 8). Effects of the various 
extracts of Moringa oleifera on insulin-release from BRIN-BD11 cells at 5.6mM glucose, 
shown in Fig. 1, showed that all the extracts produced a significant (P<0.05) and 
concentration-dependent stimulations of insulin secretion at concentrations ≥ 10µg/ml. The 
aqueous extract exhibited the most potent effects, producing a significant stimulation of 
insulin release (154% of basal rate, P < 0.05) from BRIN-BD11 cells at a concentration of 0.1 
µg/ml, with a maximum response (347% of basal rate, P<0.001) at a concentration of 
100µg/ml. Maximum insulin-releasing response (130% of basal rate, 100µg/ml, P<0.01) to 
acetone and dichloromethane extracts was moderate while a poor stimulatory effect was 





Cytotoxic effects of M. oleifera extracts 
The release of the cytosolic enzyme, lactate dehydrogenase (LDH), due to damaged plasma 
membrane was used as a marker of cytotoxicity in this study. Significant (P<0.001) release of 
the enzyme was observed in incubations involving DMSO (40% v/v). However, incubation 
with the different extracts of M. oleifera produced no significant release of LDH.  
 
DISCUSSION 
Pharmacological effects of several phytochemicals have been reported and studies providing 
scientific explanations for the ethnopharmacological use of many plants are increasing. 
Activities such as prevention of hyperglyceamia (Kar et al, 2003), inhibition of oxidative 
stress caused by streptozotocin in rats (Yassa and Tokamy, 2014) and prevention of the 
formation of advanced glycated end-products (Sangkitikomol et al, 2014) have been 
previously reported for M. oleifera extracts.  An earlier study has also reported that N-benzyl 
thiocarbamates, N-benzyl carbamates, benzyl nitriles, and benzyl ester extracted from M. 
oleifera pod stimulated insulin secretion from the insulin secreting cell-line, INS-1 (Francis et 
al, 2004). Consistent with these studies, our results indicated significant stimulation of 
insulin-release by the aqueous and acetone extracts of M. oleifera leaves from BRIN-BD11 
cells. BRIN-BD11 cell-line was generated by electrofusion of RINm5F cells with New 
England Deaconess Hospital rat pancreatic islet cells (McClenaghan et al, 1996) and has been 
used extensively to characterize insulinotropic effects of several agents, including crude plant 
extracts (Hannan et al, 2007), amphibian skin peptides (Ojo et al, 2011) and synthetic 
analogues of various endogenous peptides such as GIP and GLP-1 (Irwin et al, 2010).  
 
Compared to other extracts, the superior insulinotropic actions of the aqueous extract coupled 
with significantly higher amount of yield generated following aqueous extraction suggests 
that the active ingredient in M. oleifera leaves might be water soluble. While the aqueous 
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extracts of M. oleifera has been reported to down-regulate the expression of some pro-
inflammatory genes and increase cytotoxic effect of chemotherapy in pancreatic cancer 
cells(Berkovich  et al, 2013), no cytotoxicity was observed following the incubation of the 
aqueous, as well as other, extracts of M. oleifera with the clonal pancreatic beta cell, BRIN-
BD11. Significant release of LDH in the presence of DMSO (40% v/v) observed in this study 
is consistent with previous reports of its cytotoxic actions at concentrations above 20% (v/v) 
(Violante et al, 2002). In addition, this result indicates that the integrity of the plasma 
membrane had been preserved and the increased insulin secretion observed in the presence of 
M. oleifera extracts reported is not a consequence of damaged plasma membrane, leading to 
uncontrolled release of cytosolic enzymes.  
 
CONCLUSION 
The insulin-releasing effects reported for extracts of M. oleifera leaves in this study partly 
provide preliminary explanation for the antidiabetic effects previously reported for the plant. 
However, further studies to delineate underlying mechanisms of its insulinotropic actions are 
needed. 
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Legend to Figures 
Fig. 1: M. oleifera extraction with different solvents. DCM = Dichloromethane, ETH = 
Ethylacetate, ACE = Acetone and AQU = Aqueous 
 
Fig. 2: Effects of various extracts of M. oleifera on the release of insulin from BRIN-BD11 
clonal β-cells in the presence of 5.6 mM glucose. (*** P < 0.001, ** P < 0.01, * P < 0.05 
compared to glucose; n = 8). 
 
Fig. 3: Effects of various extracts of M. oleifera on lactose dehydrogenase from BRIN-BD11 







































































Methyl N-{4-[(4’-O-acetyl-α-L-rhamnopyranosyl )benzyl]}thiocarbamate 
Methyl N-{4-[(α-L-rhamnopyranosyl)benzyl]}carbamate 
Methyl N-{4-[(4’-Oacetyl-α-L-rhamnopyranosyl)benzyl]}carbamate 
Francis et al, 2004; Fahey, 2005 
 
 
